NEW YORK, NY / ACCESSWIRE / December 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Zosano Pharma Corporation (NASDAQ:ZSAN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/zosano-pharma-corporation-loss-submission-form?prid=11805&wire=1
Lead Plaintiff Deadline: December 28, 2020
Class Period: February 13, 2017 - September 30, 2020

Allegations against ZSAN include that: (1) the Company's clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots; (2) pharmocokinetic studies submitted in connection with the Company's New Drug Application included patients exhibiting unexpected high plasma concentrations of zolmitriptan; (3) as a result of the foregoing differences among patient results, the U.S. Food and Drug Administration was reasonably likely to require further studies to support regulatory approval of the Company's lead product candidate, Qtrypta; (4) as a result, regulatory approval of Qtrypta was reasonably likely to be delayed; and (5) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Alibaba Group Holding Limited (NYSE:BABA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/alibaba-group-holding-limited-loss-submission-form?prid=11805&wire=1
Lead Plaintiff Deadline: January 12, 2021
Class Period: July 20, 2020 - November 3, 2020

Allegations against BABA include that: (1) Ant Small and Micro Financial Services Group Co., Ltd. ("Ant Group"), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group's business; (3) as a result of the foregoing, Ant Group's initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Berry Corporation (NASDAQ:BRY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/berry-corporation-loss-submission-form?prid=11805&wire=1
Lead Plaintiff Deadline: January 21, 2021
Lawsuit on behalf of investors who purchased: (a) Berry common stock pursuant and/or traceable to the Company's initial public offering conducted on or about July 26, 2018; or (b) Berry securities between July 26, 2018 and November 3, 2020, both dates inclusive